CN Patent

CN101849944A — 治疗2型糖尿病的药物组合物

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2010-10-06 · 16y expired

What this patent protects

本发明公开了治疗2型糖尿病的药物组合物，特别是含有(R)-7-[3-氨基-4-(2，4，5-三氟-苯基)-丁酰]-3-三氟甲基-5，6，7，8-四氢-咪唑并[1，5-a]吡嗪-1-羧酸甲酯或者其盐和二甲双胍或者其盐(如盐酸盐)的固定剂量组合的药物组合物，制备所述药物组合物的方法和使用所述药物组合物治疗2型糖尿病的方法。

USPTO Abstract

本发明公开了治疗2型糖尿病的药物组合物，特别是含有(R)-7-[3-氨基-4-(2，4，5-三氟-苯基)-丁酰]-3-三氟甲基-5，6，7，8-四氢-咪唑并[1，5-a]吡嗪-1-羧酸甲酯或者其盐和二甲双胍或者其盐(如盐酸盐)的固定剂量组合的药物组合物，制备所述药物组合物的方法和使用所述药物组合物治疗2型糖尿病的方法。

Drugs covered by this patent

metformin-hydrochloride (METFORMIN HYDROCHLORIDE)

Patent Metadata

Patent number: CN101849944A
Jurisdiction: CN
Classification: —
Expires: 2010-10-06
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Hengrui Medicine Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.